Compare Gudang Garam Tbk. (GGRM) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gudang Garam Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Gudang Garam Tbk. trades at Rp19,375 (market cap 37.52T, 424.7K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Gudang Garam Tbk. is far larger — about 359.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| GGRM | SCPI | |
|---|---|---|
Market Cap | 37.52T | 104.4B |
Volume | 424.7K | — |
Lot | 4.25K | — |
Turnover | 8.22B | — |
Average Price | 19,361.49 | — |
Value | 8.22B | — |
Indicative Equilibrium Price | 19,375 | — |
Indicative Equilibrium Volume | 168 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gudang Garam Tbk.
PT Gudang Garam Tbk (the Company), previously named as PT Perusahaan Rokok Tjap Gudang Garam Kediri was established by Deed of Mr. Suroso S.H., acting notary public in Kediri, dated 30 June 1971 No. 10 amended by deed of the same notary dated 13 October 1971 No. 13. The Company is a continuation of a Proprietorship which was established in 1958. In 1969, the Company changed its legal status to a Partnership and in 1971 it was further changed its legal entity as a Limited Liability Company. Commercial operation was commenced in 1958.
Read more on GGRM →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
